PREDILIFE SA (ALPRE.PA) Stock Fundamental Analysis
Europe • Euronext Paris • EPA:ALPRE • FR0010169920
3.23 EUR
+0.03 (+0.94%)
Last: Jan 30, 2026, 07:00 PM
ALPRE gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 85 industry peers in the Biotechnology industry. Both the profitability and financial health of ALPRE have multiple concerns. ALPRE is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- In the past year ALPRE has reported negative net income.
- In the past year ALPRE has reported a negative cash flow from operations.
- ALPRE had negative earnings in each of the past 5 years.
- ALPRE had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- ALPRE's Return On Assets of -290.42% is on the low side compared to the rest of the industry. ALPRE is outperformed by 92.94% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -290.42% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-115.89%
ROA(5y)-97.74%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- With an excellent Gross Margin value of 98.10%, ALPRE belongs to the best of the industry, outperforming 96.47% of the companies in the same industry.
- In the last couple of years the Gross Margin of ALPRE has grown nicely.
- The Profit Margin and Operating Margin are not available for ALPRE so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 98.1% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.18%
GM growth 5Y8.21%
2. Health
2.1 Basic Checks
- ALPRE does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, ALPRE has more shares outstanding
- Compared to 5 years ago, ALPRE has more shares outstanding
- Compared to 1 year ago, ALPRE has a worse debt to assets ratio.
2.2 Solvency
- ALPRE has an Altman-Z score of -38.94. This is a bad value and indicates that ALPRE is not financially healthy and even has some risk of bankruptcy.
- The Altman-Z score of ALPRE (-38.94) is worse than 83.53% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -38.94 |
ROIC/WACCN/A
WACC6.7%
2.3 Liquidity
- ALPRE has a Current Ratio of 0.45. This is a bad value and indicates that ALPRE is not financially healthy enough and could expect problems in meeting its short term obligations.
- ALPRE's Current ratio of 0.45 is on the low side compared to the rest of the industry. ALPRE is outperformed by 84.71% of its industry peers.
- A Quick Ratio of 0.45 indicates that ALPRE may have some problems paying its short term obligations.
- ALPRE has a worse Quick ratio (0.45) than 83.53% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.45 | ||
| Quick Ratio | 0.45 |
3. Growth
3.1 Past
- ALPRE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 20.51%, which is quite impressive.
- Looking at the last year, ALPRE shows a very strong growth in Revenue. The Revenue has grown by 134.19%.
- Measured over the past years, ALPRE shows a very strong growth in Revenue. The Revenue has been growing by 84.77% on average per year.
EPS 1Y (TTM)20.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%21.88%
Revenue 1Y (TTM)134.19%
Revenue growth 3Y51.41%
Revenue growth 5Y84.77%
Sales Q2Q%148.77%
3.2 Future
- Based on estimates for the next years, ALPRE will show a very negative growth in Earnings Per Share. The EPS will decrease by -12.92% on average per year.
- ALPRE is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 116.42% yearly.
EPS Next Y-10.83%
EPS Next 2Y-12.92%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year50.7%
Revenue Next 2Y51.3%
Revenue Next 3Y161.34%
Revenue Next 5Y116.42%
3.3 Evolution
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for ALPRE. In the last year negative earnings were reported.
- Also next year ALPRE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A cheap valuation may be justified as ALPRE's earnings are expected to decrease with -12.92% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-12.92%
EPS Next 3YN/A
5. Dividend
5.1 Amount
- ALPRE does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
PREDILIFE SA / ALPRE.PA FAQ
Can you provide the ChartMill fundamental rating for PREDILIFE SA?
ChartMill assigns a fundamental rating of 2 / 10 to ALPRE.PA.
What is the valuation status for ALPRE stock?
ChartMill assigns a valuation rating of 0 / 10 to PREDILIFE SA (ALPRE.PA). This can be considered as Overvalued.
How profitable is PREDILIFE SA (ALPRE.PA) stock?
PREDILIFE SA (ALPRE.PA) has a profitability rating of 1 / 10.
How financially healthy is PREDILIFE SA?
The financial health rating of PREDILIFE SA (ALPRE.PA) is 0 / 10.